Search results for "organometalli"

showing 10 items of 395 documents

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions : results of a mu…

2008

The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividual, randomized study design, both contrast agents were compared in a total of 471 patients regarding their diagnostic accuracy, sensitivity, and specificity to correctly classify focal lesions of the kidney. To test for noninferiority the diagnostic accuracy rates for both contrast agents were compared with CT results based on a blinded reading. The average diagnostic accuracy across the three bli…

Gadobutrol; Gadopentate dimeglumine; Renal lesions; MRI; Diagnostic differentiation; NoninferiorityGadolinium DTPAMalemedicine.medical_specialtyContrast MediaRenal lesionsSensitivity and SpecificityGadobutrollaw.inventionGadobutrolPrecontrastRandomized controlled trialmagnetic resonance contrast medialawmedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingSingle-Blind Methodddc:610Neuroradiologymedicine.diagnostic_testbusiness.industryDiagnostic differentiationUltrasoundReproducibility of ResultsMagnetic resonance imagingInterventional radiologyGeneral MedicineNoninferiorityMiddle AgedImage EnhancementMagnetic Resonance ImagingKidney NeoplasmsClinical trialEuropeRadiology Nuclear Medicine and imagingFemaleGadopentate dimeglumineRadiologybusinessNuclear medicinemedicine.drugMRI
researchProduct

MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.

2016

Purpose: The purpose of the study is to compare the MR-imaging features of hepatocellular carcinoma (HCC) capsule appearance on gadoxetic acid and gadobenate dimeglumine-enhanced MR imaging, using imaging-based presumptive diagnosis of HCC as the reference standard. Methods: Gadoxetic acid and gadobenate dimeglumine-enhanced MR imaging of 51 patients with 71 HCCs were retrospectively reviewed. Three readers graded in consensus, using a five-point scale, the presence (score 4–5) of capsule appearance on images obtained during T1-weighted GRE portal venous phase (PVP), 3-min phase, and hepatobiliary phase (HBP). The Fisher's exact test and the t student unpaired test were performed. Results: …

Gadolinium DTPALiver CirrhosisMaleCirrhotic livermedicine.medical_specialtyGadoxetic acidCarcinoma HepatocellularHepatocellular carcinomaUrologyGadoxetic acidContrast MediaSensitivity and Specificity030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMeglumineInternal medicineGadobenate dimegluminemedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingGADOBENATE DIMEGLUMINECapsuleAgedRetrospective StudiesAged 80 and overRadiological and Ultrasound Technologybusiness.industryLiver NeoplasmsGastroenterologyCapsuleReproducibility of ResultsHepatologyHCCSMiddle Agedmedicine.diseaseImage EnhancementMr imagingMagnetic Resonance Imagingdigestive system diseasesLiver030220 oncology & carcinogenesisHepatocellular carcinomaFemaleRadiologybusinessMR imagingmedicine.drugAbdominal radiology (New York)
researchProduct

Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?

2020

Purpose: To compare the level of parenchymal and portal venous enhancement in the portal venous phase (PVP) in cirrhotic patients undergoing gadoxetate disodium- and gadobenate dimeglumine-enhanced MRI. Methods: In this retrospective study, 84 cirrhotic patients (mean age ± SD: 66 ± 13 years) who underwent contrast-enhanced MRI with both gadoxetate disodium and gadobenate dimeglumine between 2012 and 2018 were included. Two readers measured signal intensities of hepatic parenchyma, portal vein and psoas muscle on precontrast and PVP. Relative enhancement (RE), image contrast, and portal vein-to-liver contrast difference were calculated. Intraindividual differences were compared with the Wil…

Gadolinium DTPALiver Cirrhosismedicine.medical_specialtyCirrhosisUrologyPortal veinContrast MediaPortal venous phase030218 nuclear medicine & medical imagingGadoxetate Disodium03 medical and health sciences0302 clinical medicinePrecontrastMeglumineInternal medicineGadobenate dimegluminemedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingGADOBENATE DIMEGLUMINEAgedRetrospective StudiesCirrhosis Portal vein Gadobenate dimeglumine Gadoxetate disodium Hepatic parenchymaHepatic parenchymaRadiological and Ultrasound Technologybusiness.industryGastroenterologyHepatologyMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingCirrhosisHepatic parenchyma030220 oncology & carcinogenesisPortal veinGadoxetate disodiumNuclear medicinebusiness
researchProduct

Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA

2019

Abstract Purpose To compare magnetic resonance imaging (MRI) findings with gadoxetic acid and gadobenate dimeglumine for the diagnosis of hepatic hemangiomas. Materials and Methods In this retrospective study, we included 26 hemangiomas (mean size was 14 mm ± 10 mm) in 19 patients (mean age 60 ± 14 years) scanned with both gadobenate dimeglumine MRI and gadoxetic acid MRI. For each patient, we collected multiple lesion variables including location, number, size and enhancement pattern on arterial, portal venous, 3-minute and hepatobiliary phases with both gadoxetic acid and gadobenate dimeglumine. The enhancement pattern with the two contrast agents was then compared. Results The typical en…

Gadolinium DTPAMaleHepatic HemangiomaGadoxetic acidGd boptaContrast MediaGd-EOB-DTPAEnhancement patternliver030218 nuclear medicine & medical imaging03 medical and health sciencesmagnetic resonance imaging.Meglumine0302 clinical medicineImage Interpretation Computer-AssistedOrganometallic CompoundsmedicineHumansRadiology Nuclear Medicine and imagingRetrospective Studiesmedicine.diagnostic_testbusiness.industryLiver NeoplasmsMagnetic resonance imagingMiddle AgedImage EnhancementMagnetic Resonance ImagingHyperintensitygadoxetic acid030220 oncology & carcinogenesisFemaleNuclear medicinebusinessHemangiomaArterial phasemedicine.druggadobenate dimeglumine
researchProduct

Synthesis and Supramolecular Association of Immobilized NCN-Pincer Platinum(II) Complexes on Hyperbranched Polyglycerol Supports

2004

Pertosylation of hyperbranched polyglycerol (M(n)=2000; M(w)/M(n)=1.3) followed by partial displacement of the tosyl groups with carboxylic acid functionalized NCN-pincer platinum(II) complexes [PtI-2,6-(NMe(2)CH(2))(2)C(6)H(2)-4-COOH], resulted in covalent attachment of the NCN-pincer complexes to the polyglycerol. These functionalized hyperbranched macromolecules have been characterized by (1)H, (13)C, and (195)Pt NMR, UV-visible, and IR spectroscopy. The presence of Pt and I atoms renders them directly visible by transmission electron microscopy (TEM) without staining procedures, which offers images of associated hyperbranched macromolecules. TEM micrographs show disk-shaped structures w…

GlycerolMagnetic Resonance SpectroscopyMolecular StructureNitrogenPolymersOrganic ChemistrySupramolecular chemistrychemistry.chemical_elementInfrared spectroscopyGeneral ChemistryCarbonCatalysisPincer movementchemistry.chemical_compoundTosylchemistryCovalent bondPolymer chemistryOrganometallic CompoundsMoleculeSpectrophotometry UltravioletPlatinumPlatinumMacromoleculeChemistry - A European Journal
researchProduct

Cluster Preface: Heterogeneous Catalysis

2016

International audience; Jean-Cyrille Hierso is full professor of Chemistry since 2009, heading the group of ‘Organometallic Chemistry and Catalysis’ at the Institute of Molecular Chemistry at the University of Bourgogne Franche-Comté (UBFC). He has interest in the fields of organometallic chemistry, ligand design, homo- and heterogeneous catalysis, chemical physics, and material sciences. In 2011 he was awarded the National Prize for Coordination Chemistry from the French Chemical Society (SCF), and at the end of 2012 he was elected a junior Member of the French Professors Academy ‘Institut Universitaire de France’ (IUF).Yasuhiro Uozumi is a full professor at the Institute for Molecular Sci…

Green chemistryMolecular chemistry010405 organic chemistryOrganic ChemistryLibrary scienceNanotechnology010402 general chemistryHeterogeneous catalysis01 natural sciencesMolecular science[ CHIM ] Chemical Sciences0104 chemical sciencesChemical societychemistry.chemical_compoundsustainable chemistry - nanocatalysts - organocatalysts - gold - palladium - nanoparticles - peptides - polymer supports - inorganic supports - nanotubes - epoxidation - esterification - cross-coupling - C–H functionalization - oxidation - (hetero)arenes - Kinetics - supramolecular assembly - recovery - recyclingchemistryTeam leader[CHIM]Chemical SciencesOrganometallic chemistry
researchProduct

Metal-Organic Nanocapsules with Functionalized s-Heptazine Ligands.

2020

A metalloorganic capsule was synthesized where the ligand is a derivative of heptazine with three carboxylic groups that are coordinated to CuII cations, forming paddle-wheel motifs. Each nanocapsule is neutral, with 12 CuII centers and 8 ligands adopting a rhombicuboctahedron shape. It has almost 3 nm diameter, and the main intermolecular interactions in the solid are π··· π stacking between the C6N7 heptazine moieties. The nanocapsules can form monolayers deposited on graphite as observed by atomic force microscopy, which confirms their stability in solution. peerReviewed

HeptazineNanociènciaLigandorganometalliyhdisteetMoleculesLigandsNanocapsulesInorganic ChemistryMetalchemistry.chemical_compoundNanoscienceLligandschemistryvisual_artPolymer chemistryvisual_art.visual_art_mediumsupramolekulaarinen kemiananohiukkasetPhysical and Theoretical ChemistryMolèculeshuman activitiesDerivative (chemistry)Inorganic chemistry
researchProduct

Chemistry of ?-hydridobis[pentacarbonylchromium(0)] species. Part III. Redox reactions with mercury(II) compounds and iodine

1981

[Cr2(CO)10(μ-H)]− undergoes ready hydride substitution on reaction with HgX2 (X = Cl, Br, I or SCN) or with iodine in acetone, yielding [Cr2(CO)10(μ-X)]− complex species which can be converted quantitatively into [Cr(CO)5X]− anions by reactions conducted in the presence of an excess of X−.

HydrideInorganic chemistryMetals and Alloyschemistry.chemical_elementIodineMedicinal chemistryRedoxMercury (element)CatalysisInorganic ChemistryPart iiichemistry.chemical_compoundchemistryMaterials ChemistryAcetoneOrganometallic chemistryTransition Metal Chemistry
researchProduct

Hydrogen-ion driven molecular motions in Cu2+-complexes of a ditopic phenanthrolinophane ligand

2004

One of the first kinetic evaluations of a metal ion interchange between the two coordination sites of a ditopic macrocycle is presented. Garcia-España Monsonis, Enrique, Enrique.Garcia-Es@uv.es ; Soriano Soto, Concepción, Concepcion.Soriano@uv.es ; Verdejo Viu, Begoña, Begona.Verdejo@uv.es

Hydrogen ionHydrogenStereochemistryUNESCO::QUÍMICAKineticschemistry.chemical_elementHydrocarbons CyclicHydrogen ; Cu2 ; Phenanthrolinophane ; Ditopic macrocycleDitopic macrocycleLigands:QUÍMICA [UNESCO]CatalysisIonPhenanthrolinophaneCu2Materials ChemistryMolecular motionOrganometallic CompoundsLigandChemistryUNESCO::QUÍMICA::Química inorgánicaMetals and AlloysGeneral ChemistryHydrogen-Ion Concentration:QUÍMICA::Química inorgánica [UNESCO]Surfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsCrystallographyKineticsCeramics and CompositesProtonsCopperHydrogen
researchProduct

Preparation and structure of the 17-electron (η5-C5R5)Mo(OH)2(dppe) (R=Me, Et) organometallic compounds containing two gem-terminal hydroxide ligands

2000

International audience; Oxidation of (η5-C5R5)MoH3(dppe) (R=Me, Et) by Cp2Fe+ in wet THF leads to the formation of the corresponding (η5-C5R5)Mo(OH)2(dppe). These compounds show a low-potential reversible oxidation wave. The structure of the C5Et5 complex has been confirmed by X-ray diffraction methods: triclinic; space group ; a=11.030(1); b=12.533(1); c=16.241 (1) Å; α=68.585(7); β=75.197(5); γ=83.991(7)°; V=2020.6(3) Å3; Z=2; Dcalc=1.324 g cm−3, μ(Mo–Kα)=0.441 mm−1; R1=0.0325; wR2=0.0875 for 415 parameters and 6823 independent reflections [Rint=0.0177] with I=2σ(I). The molecule shows a four-legged piano-stool geometry with two terminal OH ligands in a relative trans configuration. The c…

Hydroxide complexeschemistry.chemical_elementHalf-sandwich complexesElectronTriclinic crystal system010402 general chemistry01 natural sciencesBiochemistrylaw.inventionInorganic Chemistrychemistry.chemical_compoundTrans configurationlawOxidationMaterials ChemistryMolecule[CHIM.COOR]Chemical Sciences/Coordination chemistryPhysical and Theoretical ChemistryElectron paramagnetic resonanceGroup 2 organometallic chemistryMolybdenum010405 organic chemistryOrganic ChemistryHydride complexes0104 chemical sciencesCrystallographychemistryMolybdenumHydroxide
researchProduct